60.43% of Aligos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aligos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Royal Bank of Canada	644,553	$0.48M	0.0%	-23.3%	0.860%
11/14/2023	Newtyn Management LLC	920,000	$0.69M	0.2%	+2.2%	1.228%
8/15/2023	Royal Bank of Canada	840,393	$0.82M	0.0%	+1,779.4%	1.932%
8/11/2023	Renaissance Technologies LLC	430,555	$0.42M	0.0%	-4.9%	1.003%
8/11/2023	Geode Capital Management LLC	256,592	$0.25M	0.0%	+28.4%	0.598%
8/10/2023	Charles Schwab Investment Management Inc.	31,383	$30K	0.0%	N/A	0.073%
5/16/2023	State Street Corp	97,423	$85K	0.0%	+60.2%	0.227%
5/15/2023	Logos Global Management LP	1,000,000	$0.87M	0.1%	N/A	2.329%
5/15/2023	Two Sigma Investments LP	56,857	$50K	0.0%	-37.1%	0.132%
5/12/2023	Renaissance Technologies LLC	452,860	$0.40M	0.0%	-14.9%	1.055%
5/11/2023	Acadian Asset Management LLC	564,715	$0.49M	0.0%	+68.7%	1.315%
2/15/2023	Tang Capital Management LLC	2,816,391	$2.68M	0.4%	+68.2%	6.577%
2/15/2023	Millennium Management LLC	371,319	$0.35M	0.0%	+11.8%	0.867%
2/14/2023	Point72 Asset Management L.P.	905,896	$0.86M	0.0%	-1.2%	2.116%
2/14/2023	Two Sigma Investments LP	90,418	$86K	0.0%	-27.3%	0.211%
2/13/2023	Renaissance Technologies LLC	532,260	$0.51M	0.0%	-27.1%	1.243%
2/13/2023	Geode Capital Management LLC	199,858	$0.19M	0.0%	+5.0%	0.467%
2/10/2023	New York Life Investment Management LLC	263,832	$0.25M	0.0%	+12.7%	0.616%
2/10/2023	HRT Financial LP	66,259	$63K	0.0%	-34.9%	0.155%
11/15/2022	Tang Capital Management LLC	1,674,166	$1.84M	0.2%	+8.2%	3.910%
11/15/2022	Two Sigma Investments LP	124,426	$0.14M	0.0%	-36.3%	0.291%
11/15/2022	Vanguard Group Inc.	1,089,992	$1.20M	0.0%	+2.6%	2.546%
11/15/2022	Citadel Advisors LLC	73,295	$80K	0.0%	-53.9%	0.171%
11/14/2022	Point72 Asset Management L.P.	917,036	$1.01M	0.0%	+14.6%	2.142%
11/14/2022	Renaissance Technologies LLC	730,598	$0.80M	0.0%	-19.1%	1.706%
11/14/2022	Ergoteles LLC	52,889	$58K	0.0%	-49.0%	0.124%
11/2/2022	Rockefeller Capital Management L.P.	77,499	$85K	0.0%	N/A	0.181%
8/18/2022	Goldman Sachs Group Inc.	98,959	$0.12M	0.0%	-24.6%	0.231%
8/15/2022	AQR Capital Management LLC	48,045	$58K	0.0%	N/A	0.112%
8/15/2022	State Street Corp	60,823	$74K	0.0%	-85.0%	0.142%
8/15/2022	Citadel Advisors LLC	158,939	$0.19M	0.0%	+2,408.5%	0.371%
8/15/2022	Millennium Management LLC	464,409	$0.56M	0.0%	N/A	1.085%
8/15/2022	Pivotal bioVenture Partners Investment Advisor LLC	743,215	$0.90M	0.5%	-15.2%	1.736%
8/13/2022	Renaissance Technologies LLC	903,100	$1.09M	0.0%	+149.3%	2.115%
8/12/2022	Northern Trust Corp	32,604	$39K	0.0%	-83.0%	0.076%
7/25/2022	Silverarc Capital Management LLC	58,392	$71K	0.0%	+447.8%	0.137%
7/18/2022	Brinker Capital Investments LLC	44,649	$54K	0.0%	N/A	0.105%
7/11/2022	Wedmont Private Capital	20,741	$25K	0.0%	N/A	0.049%
6/7/2022	Bank of America Corp DE	1,184,258	$2.55M	0.0%	+1.7%	2.774%
5/17/2022	Mirabella Financial Services LLP	40,900	$88K	0.0%	N/A	0.096%
5/16/2022	Goldman Sachs Group Inc.	131,162	$0.28M	0.0%	+343.3%	0.307%
5/16/2022	PDT Partners LLC	26,694	$57K	0.0%	N/A	0.063%
5/16/2022	Wellington Management Group LLP	471,140	$1.01M	0.0%	-86.8%	1.104%
5/16/2022	State Street Corp	404,756	$0.87M	0.0%	+3.8%	0.948%
5/16/2022	Prelude Capital Management LLC	27,100	$58K	0.0%	N/A	0.063%
5/16/2022	Novo Holdings A S	1,950,000	$4.19M	0.2%	-25.4%	4.567%
5/13/2022	Renaissance Technologies LLC	362,314	$0.78M	0.0%	+564.8%	0.849%
5/13/2022	Northern Trust Corp	191,827	$0.41M	0.0%	-5.9%	0.449%
5/13/2022	Charles Schwab Investment Management Inc.	123,831	$0.27M	0.0%	-11.0%	0.290%
5/13/2022	XTX Topco Ltd	43,936	$94K	0.0%	N/A	0.103%
5/13/2022	Vanguard Group Inc.	1,284,763	$2.76M	0.0%	-6.6%	3.010%
5/12/2022	Acadian Asset Management LLC	175,721	$0.38M	0.0%	N/A	0.412%
5/6/2022	IndexIQ Advisors LLC	192,976	$0.42M	0.0%	N/A	0.452%
4/19/2022	Denali Advisors LLC	16,000	$34K	0.0%	N/A	0.037%
2/14/2022	Virtus ETF Advisers LLC	14,209	$0.17M	0.1%	+108.5%	0.033%
2/14/2022	Point72 Asset Management L.P.	110,488	$1.31M	0.0%	+13.6%	0.259%
2/11/2022	Ensign Peak Advisors Inc	7,320	$87K	0.0%	N/A	0.017%
2/8/2022	Bank of America Corp DE	1,164,300	$13.82M	0.0%	+3,351.9%	2.733%
2/8/2022	ProShare Advisors LLC	10,177	$0.12M	0.0%	N/A	0.024%
2/8/2022	Northern Trust Corp	203,799	$2.42M	0.0%	+2.8%	0.478%
11/17/2021	Altium Capital Management LP	33,492	$0.52M	0.1%	N/A	0.079%
11/16/2021	Janus Henderson Group PLC	2,440,476	$37.66M	0.0%	+8.0%	5.728%
11/16/2021	Two Sigma Investments LP	89,863	$1.39M	0.0%	N/A	0.211%
11/16/2021	Wellington Management Group LLP	3,829,383	$59.39M	0.0%	-8.3%	8.987%
11/15/2021	Point72 Asset Management L.P.	97,300	$1.51M	0.0%	N/A	0.228%
11/15/2021	California State Teachers Retirement System	32,126	$0.50M	0.0%	+24.1%	0.075%
11/15/2021	Sphera Funds Management LTD.	249,197	$3.87M	0.3%	N/A	0.585%
11/12/2021	Renaissance Technologies LLC	53,200	$0.83M	0.0%	N/A	0.125%
11/12/2021	Jump Financial LLC	16,100	$0.25M	0.0%	N/A	0.038%
11/12/2021	Macquarie Group Ltd.	5,786	$90K	0.0%	N/A	0.014%
11/12/2021	The Manufacturers Life Insurance Company	12,276	$0.19M	0.0%	+10.8%	0.029%
11/12/2021	Credit Suisse AG	13,624	$0.21M	0.0%	N/A	0.032%
11/12/2021	Geode Capital Management LLC	313,655	$4.86M	0.0%	+22.8%	0.736%
11/10/2021	Goldman Sachs Group Inc.	23,737	$0.37M	0.0%	-37.5%	0.056%
11/10/2021	Citigroup Inc.	3,122	$48K	0.0%	+49.7%	0.007%
11/10/2021	O Shaughnessy Asset Management LLC	3,261	$51K	0.0%	N/A	0.008%
11/9/2021	BlackRock Inc.	1,239,562	$19.23M	0.0%	+14.3%	2.909%
11/8/2021	Swiss National Bank	56,200	$0.87M	0.0%	+67.3%	0.132%
11/5/2021	Advisor Group Holdings Inc.	4,500	$70K	0.0%	N/A	0.011%
11/4/2021	Deutsche Bank AG	83,752	$1.30M	0.0%	-13.2%	0.197%
11/1/2021	SG Americas Securities LLC	8,383	$0.13M	0.0%	N/A	0.020%
8/17/2021	Logos Global Management LP	212,785	$4.34M	0.4%	-55.3%	0.499%
8/17/2021	Metropolitan Life Insurance Co NY	6,361	$0.13M	0.0%	N/A	0.015%
8/17/2021	MetLife Investment Management LLC	8,308	$0.17M	0.0%	N/A	0.019%
8/17/2021	Price T Rowe Associates Inc. MD	27,230	$0.56M	0.0%	N/A	0.064%
8/17/2021	Acuta Capital Partners LLC	214,254	$4.37M	1.7%	N/A	0.503%
8/16/2021	California State Teachers Retirement System	25,890	$0.53M	0.0%	+61.3%	0.061%
8/16/2021	Charles Schwab Investment Management Inc.	89,039	$1.82M	0.0%	+24.4%	0.209%
8/16/2021	State Street Corp	298,587	$6.09M	0.0%	+73.5%	0.701%
8/16/2021	Nuveen Asset Management LLC	64,216	$1.31M	0.0%	+163.8%	0.151%
8/16/2021	Goldman Sachs Group Inc.	37,968	$0.77M	0.0%	-9.1%	0.089%
8/13/2021	HarbourVest Partners LLC	18,783	$0.38M	0.0%	N/A	0.049%
8/13/2021	Northern Trust Corp	178,014	$3.63M	0.0%	+56.6%	0.467%
8/13/2021	Geode Capital Management LLC	255,348	$5.21M	0.0%	+42.9%	0.669%
8/13/2021	Vanguard Group Inc.	983,296	$20.05M	0.0%	+59.9%	2.577%
8/12/2021	Versant Venture Management LLC	2,320,381	$47.30M	15.7%	-29.5%	6.082%
8/12/2021	State of Wisconsin Investment Board	20,725	$0.42M	0.0%	N/A	0.054%
8/12/2021	Legal & General Group Plc	2,647	$53K	0.0%	+153.3%	0.007%
8/12/2021	JPMorgan Chase & Co.	25,909	$0.53M	0.0%	-12.3%	0.068%
8/12/2021	The Manufacturers Life Insurance Company	11,084	$0.23M	0.0%	N/A	0.029%

Data available starting January 2016

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-097558, which is in Phase I clinical trial for the treatment of coronavirus; and ALG-000184, a capsid assembly modulator, which is completed Phase 1b clinical trial to treat chronic hepatitis B (CHB). The company also develops ALG-055009, a small molecule THR-ß agonist that is in the Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). In addition, it develops siRNA drug candidate, ALG-125755, which is in Phase I clinical trial for the treatment of CHB. Aligos Therapeutics, Inc. has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; Emory University to provide hepatitis B virus capsid assembly modulator technology; research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors; and Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH, as well as a research collaboration and development agreement with Xiamen Amoytop Biotech Co., Ltd. to research and develop oligonucleotide compounds for the treatment of liver diseases.. The company was incorporated in 2018 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.58

$0.55

$0.72

50 Day Range

MA: $0.70

$0.58

$0.80

52 Week Range

Now: $0.58

$0.54

$2.41

Volume

2,633,978 shs

Average Volume

194,825 shs

Market Capitalization

$43.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.22

Who are the company insiders with the largest holdings of Aligos Therapeutics?: Aligos Therapeutics' top insider shareholders include:
Carole Nuechterlein (Director)
Learn More about top insider investors at Aligos Therapeutics.
Who are the major institutional investors of Aligos Therapeutics?: Aligos Therapeutics' top institutional shareholders include:
Newtyn Management LLC — 1.23%
Royal Bank of Canada — 0.86%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Aligos Therapeutics stock.
Which major investors are selling Aligos Therapeutics stock?: During the last quarter, ALGS stock was sold by these institutional investors:
Royal Bank of Canada
Which major investors are buying Aligos Therapeutics stock?: During the last quarter, ALGS stock was acquired by institutional investors including:
Newtyn Management LLC

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

ALGS Insider Trading

Aligos Therapeutics Insider Trading History Chart

Aligos Therapeutics Share Price & Price History

Aligos Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Aligos Therapeutics (NASDAQ:ALGS)